|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
3.420 -0.030 (-0.870%) | 2022/12 - Final RMB(K¥) | %Chg (Final to Final) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 5,981,656 | 15.027% | 5,200,226 | 5,539,641 | 6,357,851 | 5,173,385 | |
| Cost of Sales | (1,841,140) | 2.088% | (1,803,486) | (1,549,027) | (1,478,684) | (1,123,971) | |
| Gross Profit | 4,140,516 | 21.897% | 3,396,740 | 3,990,614 | 4,879,167 | 4,049,414 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 831 | 18.545% | 701 | 1,726 | 1,214 | 897 | |
| Profit / (Loss) before Taxation | 669,762 | -- | (74,557) | 942,174 | 1,633,926 | 1,473,470 | |
| Taxation | (86,466) | 23.125% | (70,226) | (238,909) | (279,829) | (167,475) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 21,511 | 107.016% | 10,391 | 3,321 | 42,077 | (2,622) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 604,807 | -- | (134,392) | 706,586 | 1,396,174 | 1,303,373 | |
| Net Finance Costs / (Income) | 383,082 | 28.784% | 297,462 | 313,597 | 199,466 | 107,918 | |
| Depreciation & Amortisation | 671,313 | 15.349% | 581,982 | 510,899 | 455,660 | 317,185 | |
| Directors' Emoluments | -- | -- | 10,694 | 12,176 | 10,977 | 10,232 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 17.380 | -- | -3.900 | 22.170 | 43.580 | 40.620 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 11.300 | 10.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | 25.929% | 24.618% |
| Cash flow per share ($) | -- | -- | 0.053 | 0.324 | 0.444 | 0.326 |
| NBV per share ($) | 2.867 | -- | 2.314 | 2.339 | 2.726 | 2.384 |
| Remarks: | Real time quote last updated: 29/05/2023 13:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 604,807 |
| %Change | -- |
| EPS / (LPS) | RMB 0.174 |
| NBV Per Share (¥) | RMB 2.867 |